Boule Diagnostics AB (STU:8BD) LT-Debt-to-Total-Asset : 0.09 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Boule Diagnostics AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Boule Diagnostics AB's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.09.

Boule Diagnostics AB's long-term debt to total assets ratio declined from Dec. 2023 (0.09) to Dec. 2024 (0.09). It may suggest that Boule Diagnostics AB is progressively becoming less dependent on debt to grow their business.

Boule Diagnostics AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for Boule Diagnostics AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB LT-Debt-to-Total-Asset Chart

Boule Diagnostics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.11

0.09

Boule Diagnostics AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.09	0.09	0.09	0.10	0.09

Boule Diagnostics AB LT-Debt-to-Total-Asset Calculation

Boule Diagnostics AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	4.564	/	51.31
	=	0.09

Boule Diagnostics AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	4.564	/	51.31
	=	0.09

Boule Diagnostics AB (STU:8BD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Boule Diagnostics AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Boule Diagnostics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (STU:8BD) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

BOUL:Sweden

Address

Domnarvsgatan 4, Spanga, SWE, SE-163 53

Website

https://www.boule.com

Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB Headlines

No Headlines